药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arbutamine
Tolperisone
The risk or severity of adverse effects can be increased when Flibanserin is combined with Tolperisone.
Arbutamine
Lacosamide
The risk or severity of adverse effects can be increased when Flibanserin is combined with Lacosamide.
Arbutamine
Asenapine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Asenapine.
Arbutamine
Pizotifen
The risk or severity of adverse effects can be increased when Flibanserin is combined with Pizotifen.
Arbutamine
Mianserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Mianserin.
Arbutamine
Sertindole
The risk or severity of adverse effects can be increased when Flibanserin is combined with Sertindole.
Arbutamine
YKP-1358
The risk or severity of adverse effects can be increased when Flibanserin is combined with YKP-1358.
Arbutamine
Lumateperone
The risk or severity of adverse effects can be increased when Flibanserin is combined with Lumateperone.
Arbutamine
Cariprazine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Cariprazine.
Arbutamine
Gantacurium
The risk or severity of adverse effects can be increased when Flibanserin is combined with Gantacurium.
Arbutamine
BL-1020
The risk or severity of adverse effects can be increased when Flibanserin is combined with BL-1020.
Arbutamine
PRX-08066
The risk or severity of adverse effects can be increased when Flibanserin is combined with PRX-08066.
Arbutamine
Naluzotan
The risk or severity of adverse effects can be increased when Flibanserin is combined with Naluzotan.
Arbutamine
Naronapride
The risk or severity of adverse effects can be increased when Flibanserin is combined with Naronapride.
Arbutamine
Brivaracetam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Brivaracetam.
Arbutamine
Pimavanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Pimavanserin.
Arbutamine
Methsuximide
The risk or severity of adverse effects can be increased when Flibanserin is combined with Methsuximide.
Arbutamine
Tetrodotoxin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Tetrodotoxin.
Arbutamine
APD791
The risk or severity of adverse effects can be increased when Flibanserin is combined with APD791.
Arbutamine
Ezogabine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Ezogabine.